Acasă › Cancer ovarian › Minnesota › Minneapolis
Studii clinice pentru Cancer ovarian în Minneapolis, MN
24 studii pentru Cancer ovarian caută participanți în și în jurul orașului Minneapolis (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Minneapolis VA Medical Center, Minneapolis
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
În curs de recrutareFaza 3
- Masonic Cancer Center, University of Minnesota, Minneapolis
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · La 5 mi distanță
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · La 5 mi distanță
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
În curs de recrutareFaza 2
- University Of Minnesota /ID# 277850, Minneapolis
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
În curs de recrutareFaza 2
- University of Minnesota - Minneapolis /ID# 275718, Minneapolis
- Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park · La 5 mi distanță
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
În curs de recrutareFaza 2
- Minnesota Oncology-Minneapolis, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
În curs de recrutareFaza 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
În curs de recrutareFaza 1
- Normunity Investigational Site, Minneapolis
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- și încă 2
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
În curs de recrutareFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- și încă 2
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
În curs de recrutareFaza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
În curs de recrutareFaza 2
- 518, Minneapolis
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
În curs de recrutareFaza 2
- University of Minnesota - Masonic Cancer Center, Minneapolis
UNTOLD Ovarian Cancer Unmet Needs Survey
În curs de recrutareStudiu observațional
- Masonic Cancer Center, Minneapolis
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
În curs de recrutareFaza 1
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
În curs de recrutareFaza 3
- Minnesota Oncology Hematology PA, Minneapolis
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
În curs de recrutareVoluntari sănătoși bineveniți
- University of Minnesota, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
În curs de recrutareFaza 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Allina Health Cancer Institute, Minneapolis
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
În curs de recrutareFaza 2
- SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
- University of Minnesota, Minneapolis
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
În curs de recrutareFaza 1
- University of Minnesota, Minneapolis
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY69 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Arlington, VA46 studii
- Philadelphia, PA44 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- San Antonio, TX31 studii
- Cleveland, OH30 studii
Alte studii în Minneapolis
- Cancer pulmonar cu celule non-pătrate27 studii
- Cancer de sân27 studii
- Cancer de prostată23 studii
- Cancer (toate tipurile)22 studii
- Insuficiență cardiacă21 studii
- Leucemie mieloasă acută20 studii
- Cancer pulmonar20 studii
- Cancer colorectal19 studii
- Cancer endometrial18 studii
- Boala Parkinson17 studii
- Boli cardiovasculare15 studii
- Boală coronariană13 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.